buprenorphinenaloxone
Buprenorphine-naloxone is a fixed-dose combination medication used to treat opioid use disorder. It combines buprenorphine, a partial mu-opioid receptor agonist with a ceiling effect on respiratory depression, with naloxone, an opioid antagonist intended to deter misuse. When taken sublingually as directed, naloxone has poor oral bioavailability, so the therapeutic effect mainly comes from buprenorphine. If the product is dissolved and injected, naloxone can precipitate withdrawal, reducing the appeal of injection.
Medical use is for induction and maintenance in adults with opioid dependence, aiming to reduce withdrawal
Formulations commonly include buprenorphine/naloxone tablets or sublingual films in ratios such as 4/1 mg or 8/2
Safety considerations include common adverse effects such as nausea, constipation, headache, and sedation, with a risk
Regulatory status varies by country. In many places, buprenorphine/naloxone is a controlled medication with specific prescribing